Wearables and Remote Patient Monitoring
The 10 most-read Market Scan articles of 2025, reflecting what mattered most to health care leaders this year: workforce shortages, rising cyber threats, volatile supply chains and continued experimentation by major retail and technology players seeking a foothold in care delivery.
- AHA Center for Health Innovation
- Collaboration & Partnerships
- Behavioral Health Care Delivery
- Telling the Hospital Story
- Consumerism
- Artificial Intelligence (AI)
- Heart Disease, Cancer, Diabetes, and Other Chronic Diseases
- Wearables and Remote Patient Monitoring
- Robots and Robotics
- Nursing Thought Leaders
A new study from Johns Hopkins Medicine offers hospitals a glimpse of how artificial intelligence (AI) could make prevention programs more accessible without compromising results.
A recent Sage Growth Partners survey shows that health care executives are optimistic about how artificial intelligence (AI) can help the field advance but are cautious.
Samsung's recent purchase of the digital health platform Xealth will create synergy with Samsung’s wearable technology, offering a link between home health monitoring and clinical decision-making.
Rapidly evolving remote patient monitoring (RPM) tools for behavioral health patients are giving clinicians more ways to track their progress between visits.
As consumers take a more active role in their health and have unprecedented access to health data through wearable devices, remote monitoring and other technologies, organizations are closely examining their engagement strategies and tactics.
EpiWatch — a Johns Hopkins Medicine spinout — has received FDA 510(k) premarket clearance for its seizure detection platform that runs on the Apple Watch.
The Department of Health and Human Services’ Office of Inspector General Sept. 24 recommended that additional oversight is needed to ensure that remote patient monitoring in Medicare is being used and billed appropriately, according to a report.
Recent research from the Peterson Health Technology Institute (PHTI) panned many digital diabetes management tools for failing to provide meaningful clinical benefits while raising health care spending.
The recent CES 2024 show (formerly the Consumer Electronics Show) produced a number of health care-related, attention-getting devices. Some are not commercially available yet, but these products have the potential to help patients take greater control of their health.